CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-11 | Hochman David P Director | Purchase | +3,400 | $6.18 | $21K | 459,500 |
| 2017-05-11 | CATLIN AVERY W Director | Purchase | +5,000 | $6.15 | $31K | 47,000 |
| 2017-05-11 | White Barbara Chief Medical Officer | Purchase | +2,435 | $6.12 | $15K | 168,735 |
| 2017-05-11 | Cohen Yuval Chief Executive Officer | Purchase | +3,250 | $6.01 | $20K | 56,080 |
| 2017-03-17 | White Barbara Chief Medical Officer | Purchase | +4,233 | $9.49 | $40K | 166,300 |
| 2017-03-16 | Cohen Yuval Chief Executive Officer | Exercise or conversion | +20,000 | $1.00 | $20K | 52,830 |
| 2017-03-16 | Cohen Yuval Chief Executive Officer | Exercise or conversion · Options to purchase common stock | −20,000 | $1.00 | $20K | 272,728 |
| 2017-03-13 | Moran Sean F. Chief Financial Officer | Purchase | +2,000 | $9.60 | $19K | 333,610 |
| 2017-03-01 | White Barbara Chief Medical Officer | Grant or award · Stock Option(right to buy) | +115,000 | 115,000 | ||
| 2017-03-01 | Tepper Mark President and CSO | Grant or award · Stock Option(right to buy) | +115,000 | 115,000 | ||
| 2017-03-01 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option(right to buy) | +115,000 | 115,000 | ||
| 2017-03-01 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option(right to buy) | +377,500 | 377,500 | ||
| 2016-12-02 | Moran Sean F. Chief Financial Officer | Purchase | +1,500 | $7.20 | $11K | 331,610 |
| 2016-11-22 | Cohen Yuval Chief Executive Officer | Purchase | +1,340 | $7.64 | $10K | 32,830 |
| 2016-11-22 | White Barbara Chief Medical Officer | Purchase | +1,000 | $7.75 | $8K | 162,067 |
| 2016-11-22 | Cohen Yuval Chief Executive Officer | Purchase | +1,340 | $7.64 | $10K | 12,830 |
| 2016-11-22 | HOLMER ALAN F Director | Purchase | +1,000 | $7.49 | $7K | 22,000 |
| 2016-11-22 | CATLIN AVERY W Director | Purchase | +2,000 | $7.55 | $15K | 42,000 |
| 2016-11-18 | Hochman David P Director | Purchase | +10,000 | $7.00 | $70K | 456,100 |
| 2016-10-06 | White Barbara Chief Medical Officer | Grant or award · Stock Option(right to buy) | +150,000 | 150,000 |
Page 17 of 23 · 444 trades